AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34741460 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hypoglycemia requiring medical assistance
Number of subjects: 9208
Study 34741460 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hypoglycemia requiring any assistance
Number of subjects: 9208
Study 34741460 — intervention group
Group type: COMPARATOR
Intervention: No severe hypoglycemia episodes
Number of subjects: 9208
Study 32539098 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone support
Number of subjects: 0
Study 32539098 — intervention group
Group type: EXPERIMENTAL
Intervention: Short message service support
Number of subjects: 0
Study 32539098 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35428349 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula (HFNC)
Number of subjects: 337
Study 35428349 — intervention group
Group type: COMPARATOR
Intervention: Conventional oxygen therapy
Number of subjects: 337
Study 36047018 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard protocol (SP) - comprehensive ultrasound monitoring every clinic visit
Number of subjects: 100
Study 36047018 — intervention group
Group type: COMPARATOR
Intervention: Limited protocol (LP) - limited-frequency ultrasound monitoring (only at end of treatment)
Number of subjects: 100
Study 32422099 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive and sustained vasodilation
Number of subjects: 0
Study 32422099 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 36216003 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine model for abortion
Number of subjects: 0
Study 36216003 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33792800 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (100 mg twice daily)
Number of subjects: 69
Study 33792800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 33792800 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline and Placebo (combined)
Number of subjects: 69
Study 32202705 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP0113
Number of subjects: 24
Study 32202705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 35046508 — intervention group
Group type: COMPARATOR
Intervention: Intravenous placebo (n=54)
Number of subjects: 158
Study 35046508 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose ketamine (0.2 mg/kg; n=53)
Number of subjects: 158
Study 35046508 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose ketamine (0.5 mg/kg; n=51)
Number of subjects: 158
Study 33909353 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture as adjunctive therapy
Number of subjects: 0
Study 32109179 — intervention group
Group type: EXPERIMENTAL
Intervention: Cureit (bioavailable curcumin)
Number of subjects: 0
Study 32109179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35654673 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandblasted zirconium blocks treated with 50μm aluminium oxide particles and bonded with 3M™ Scotchbond™ Universal adhesive
Number of subjects: 60
Study 35654673 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel specimens treated with 37% phosphoric acid and bonded with 3M™ Scotchbond™ Universal adhesive
Number of subjects: 60
Study 35654673 — intervention group
Group type: COMPARATOR
Intervention: Untreated zirconium blocks bonded with 3M™ Scotchbond™ Universal adhesive
Number of subjects: 60
Study 34655432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetagliptin 100 mg
Number of subjects: 66
Study 34655432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetagliptin 400 mg
Number of subjects: 66
Study 34655432 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 34655432 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin 100 mg
Number of subjects: 66
Study 34655432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetagliptin (various doses 12.5-400 mg)
Number of subjects: 66
Study 34655432 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetagliptin
Number of subjects: 66
Study 32798835 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-related behavioral activation therapy (F-BA)
Number of subjects: 1025
Study 32798835 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 1025
Study 32827200 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week exercise programme (1 group session and 3 individual sessions per week)
Number of subjects: 80
Study 35034803 — intervention group
Group type: EXPERIMENTAL
Intervention: SSIGN score
Number of subjects: 358
Study 35034803 — intervention group
Group type: EXPERIMENTAL
Intervention: Leibovich score
Number of subjects: 358
Study 35034803 — intervention group
Group type: EXPERIMENTAL
Intervention: AJCC/TNM stage
Number of subjects: 358
Study 35034803 — intervention group
Group type: EXPERIMENTAL
Intervention: ASSURE score
Number of subjects: 358
Study 35034803 — intervention group
Group type: EXPERIMENTAL
Intervention: GRANT score
Number of subjects: 358
Study 35034803 — intervention group
Group type: EXPERIMENTAL
Intervention: UISS score
Number of subjects: 358
Study 35835626 — intervention group
Group type: EXPERIMENTAL
Intervention: Edible gummies
Number of subjects: 841
Study 35835626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis packages with a helps‐you‐relax health claim
Number of subjects: 841
Study 35835626 — intervention group
Group type: COMPARATOR
Intervention: Visual displays of tetrahydrocannabinol content and health warnings
Number of subjects: 841
Study 33076693 — intervention group
Group type: EXPERIMENTAL
Intervention: LCI
Number of subjects: 1502
Study 33076693 — intervention group
Group type: COMPARATOR
Intervention: WLI
Number of subjects: 1502
Study 32611862 — intervention group
Group type: EXPERIMENTAL
Intervention: Propex Pixi
Number of subjects: 90
Study 32611862 — intervention group
Group type: EXPERIMENTAL
Intervention: Formatron D10
Number of subjects: 90
Study 32611862 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiography
Number of subjects: 90
Study 35579606 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate walking exercise (150 minutes weekly, 3 times a week for 12 weeks)
Number of subjects: 35
Study 35579606 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous walking exercise (75 minutes weekly, 3 times a week for 12 weeks)
Number of subjects: 35
Study 35579606 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 35
Study 34011237 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing with guidance to promote constructive and discourage unconstructive styles (EP+)
Number of subjects: 151
Study 34011237 — intervention group
Group type: COMPARATOR
Intervention: Expressive writing with no guidance (EP)
Number of subjects: 151
Study 33275766 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacritinib
Number of subjects: 536
Study 33275766 — intervention group
Group type: COMPARATOR
Intervention: Best Available Therapy (BAT)
Number of subjects: 536
Study 33950516 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG findings in delirious patients (burst-suppression)
Number of subjects: 91
Study 33950516 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG findings in delirious patients (rhythmic/periodic patterns)
Number of subjects: 91
Study 33950516 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG findings in delirious patients (epileptiform activity)
Number of subjects: 91
Study 33950516 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of at least one abnormal EEG finding
Number of subjects: 91
Study 36427269 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet for knowledge and prevention of HIV mother-to-child transmission
Number of subjects: 45
Study 36427269 — intervention group
Group type: COMPARATOR
Intervention: Usual service care
Number of subjects: 45
Study 33221891 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted leptin level
Number of subjects: 50508
Study 33221891 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted adiponectin level
Number of subjects: 50508
Study 33221891 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted resistin level
Number of subjects: 50508
Study 33221891 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted chemerin and retinol-blinding protein 4 levels
Number of subjects: 50508
Study 32541295 — intervention group
Group type: EXPERIMENTAL
Intervention: Fellowship-trained minimally invasive gynecologic surgery subspecialists (n=19)
Number of subjects: 68
Study 32541295 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive gynecologic surgery graduating or recently graduated fellows (n=16)
Number of subjects: 68
Study 32541295 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialists in obstetrics and gynecology (n=15)
Number of subjects: 68
Study 32541295 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduating or recently graduated residents (n=18)
Number of subjects: 68
Study 32541295 — intervention group
Group type: COMPARATOR
Intervention: Residents, fellows, and specialists in obstetrics and gynecology
Number of subjects: 68
Study 36129240 — intervention group
Group type: EXPERIMENTAL
Intervention: TAT patch
Number of subjects: 16
Study 36129240 — intervention group
Group type: COMPARATOR
Intervention: Sham patch
Number of subjects: 16
Study 32381188 — intervention group
Group type: EXPERIMENTAL
Intervention: Active side branch protection (SB-P) strategy (elective 2-stent strategy for large SBs and jailed balloon technique for small SBs)
Number of subjects: 335
Study 32381188 — intervention group
Group type: COMPARATOR
Intervention: Conventional strategy (provisional stenting for large SBs and jailed wire technique for small SBs)
Number of subjects: 335
Study 32381188 — intervention group
Group type: EXPERIMENTAL
Intervention: Jailed balloon technique for small SBs
Number of subjects: 335
Study 32381188 — intervention group
Group type: COMPARATOR
Intervention: Jailed wire technique for small SBs
Number of subjects: 335
Study 34447995 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy in asymptomatic patients (395/801)
Number of subjects: 2633
Study 34447995 — intervention group
Group type: COMPARATOR
Intervention: Usual care in symptomatic patients (406 patients)
Number of subjects: 2633
Study 34447995 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control therapy in symptomatic patients
Number of subjects: 2633
Study 34447995 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in symptom status at 24 months follow-up
Number of subjects: 2633
Study 34215703 — intervention group
Group type: EXPERIMENTAL
Intervention: belimumab 10 mg/kg every 28 days for ?7 years
Number of subjects: 142
Study 32867741 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational health check-ups
Number of subjects: 23220
Study 32867741 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician's advice to change health behavior
Number of subjects: 23220
Study 32867741 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in health promotion programs
Number of subjects: 23220
Study 32867741 — intervention group
Group type: COMPARATOR
Intervention: Asthmatic workers
Number of subjects: 23220
Study 32867741 — intervention group
Group type: COMPARATOR
Intervention: Non-asthmatic workers
Number of subjects: 23220
Study 34957386 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological rehabilitation
Number of subjects: 0
Study 34957386 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 35304924 — intervention group
Group type: EXPERIMENTAL
Intervention: adamgammadex 2 mg.kg-1
Number of subjects: 48
Study 35304924 — intervention group
Group type: EXPERIMENTAL
Intervention: adamgammadex 4 mg.kg-1
Number of subjects: 48
Study 35304924 — intervention group
Group type: EXPERIMENTAL
Intervention: adamgammadex 6 mg.kg-1
Number of subjects: 48
Study 35304924 — intervention group
Group type: EXPERIMENTAL
Intervention: adamgammadex 8 mg.kg-1
Number of subjects: 48
Study 35304924 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48
Study 35475258 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 452
Study 35475258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452
Study 35475258 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab and Placebo
Number of subjects: 452
Study 33359562 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin sulfate plus neomycin sulfate for 14 days (DT group)
Number of subjects: 105
Study 33359562 — intervention group
Group type: COMPARATOR
Intervention: No treatment (NDT group)
Number of subjects: 105
Study 34533507 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology
Number of subjects: 40
Study 34533507 — intervention group
Group type: COMPARATOR
Intervention: Traditional nursing care alone
Number of subjects: 40
Study 35875789 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 65
Study 35875789 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 65
Study 32376544 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood albumin (Hb) level
Number of subjects: 419
Study 32376544 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 419
Study 32376544 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of Hb levels by 1 standard deviation
Number of subjects: 419
Study 32376544 — intervention group
Group type: COMPARATOR
Intervention: Comparison between S0 group and the 3 arteriosclerosis groups
Number of subjects: 419
Study 35134489 — intervention group
Group type: EXPERIMENTAL
Intervention: Henna mouthwash (2% aqueous extract, prescribed twice daily)
Number of subjects: 40
Study 35134489 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gluconate 0.2% mouthwash (prescribed twice daily)
Number of subjects: 40
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Good menstrual hygiene practices
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Age range 16-19 years
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: School grade level 10
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education (primary)
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education (secondary)
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education (college)
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Having regular menses
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Good knowledge regarding menstruation
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussing menstrual hygiene with friends
Number of subjects: 546
Study 34106948 — intervention group
Group type: EXPERIMENTAL
Intervention: Obtaining money for pads from the family
Number of subjects: 546
Study 33464113 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative framing
Number of subjects: 182
Study 33464113 — intervention group
Group type: COMPARATOR
Intervention: Competitive framing
Number of subjects: 182
Study 33464113 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous behaviors (within the same 10-s interval)
Number of subjects: 182
Study 33464113 — intervention group
Group type: EXPERIMENTAL
Intervention: Lagged effects
Number of subjects: 182
Study 33464113 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality traits
Number of subjects: 182
Study 33464113 — intervention group
Group type: EXPERIMENTAL
Intervention: Situational context
Number of subjects: 182
Study 33464113 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' individual complementarity coefficients
Number of subjects: 182
Study 35026987 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (various pre/post-partum dose combinations)
Number of subjects: 1060
Study 35026987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1060
Study 32745229 — intervention group
Group type: EXPERIMENTAL
Intervention: Gravity-Assisted Passive Flexion (GAP-FLEX)
Number of subjects: 27
Study 32745229 — intervention group
Group type: COMPARATOR
Intervention: Continuous Passive Motion (CPM)
Number of subjects: 27
Study 37409839 — intervention group
Group type: EXPERIMENTAL
Intervention: Mozart sonatas
Number of subjects: 20
Study 37409839 — intervention group
Group type: COMPARATOR
Intervention: No music (control)
Number of subjects: 20
Study 34079227 — intervention group
Group type: EXPERIMENTAL
Intervention: Dezocine 0.8 mg/kg (Group D)
Number of subjects: 60
Study 34079227 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil 2 µg/kg (Group S)
Number of subjects: 60
Study 32159530 — intervention group
Group type: EXPERIMENTAL
Intervention: Free gingival graft (FGG)
Number of subjects: 63
Study 32159530 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen matrix
Number of subjects: 63
Study 32159530 — intervention group
Group type: COMPARATOR
Intervention: Apically positioned flap (control group)
Number of subjects: 63
Study 34786695 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management and education from patient navigators (PNs)
Number of subjects: 224
Study 34786695 — intervention group
Group type: COMPARATOR
Intervention: Control arm (specialty care alone)
Number of subjects: 224
Study 32112353 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity home-based aerobic exercise intervention for 5-12 weeks
Number of subjects: 34
Study 32112353 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study 35061795 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing Social Network Intervention (MI-SNI)
Number of subjects: 41
Study 35061795 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 41
Study 33238763 — intervention group
Group type: EXPERIMENTAL
Intervention: Super Pulse Thulium Fiber Laser (SP TFL)
Number of subjects: 174
Study 33238763 — intervention group
Group type: COMPARATOR
Intervention: Holmium Laser (Ho:YAG)
Number of subjects: 174
Study 32918588 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Volume Low-Intensity Training (HVLIT)
Number of subjects: 13
Study 32918588 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Frequency Training (HFT)
Number of subjects: 13
Study 32918588 — intervention group
Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 13
Study 32918588 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall response to mesocycles
Number of subjects: 13
Study 36380008 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block
Number of subjects: 60
Study 36380008 — intervention group
Group type: COMPARATOR
Intervention: Wound infiltration
Number of subjects: 60
Study 32909365 — intervention group
Group type: EXPERIMENTAL
Intervention: 180 mg of Ellagic acid per day
Number of subjects: 44
Study 32909365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 32641142 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) in addition to conventional therapy
Number of subjects: 98
Study 32641142 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment including medication therapy and invasive interventional therapy
Number of subjects: 98
Study 34905411 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Lifestyle Summer Camp and Parenting program (HLSC+HLPP)
Number of subjects: 24
Study 34905411 — intervention group
Group type: COMPARATOR
Intervention: Healthy Lifestyle Summer Camp (HLSC)
Number of subjects: 24
Study 32307431 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexidol (500 mg IV once daily for 14 days, then Mexidol Forte 250 (250 mg, 3 times a day for 60 days)
Number of subjects: 50
Study 32307431 — intervention group
Group type: COMPARATOR
Intervention: Standard basic therapy (comparison group)
Number of subjects: 50
Study 35414517 — intervention group
Group type: EXPERIMENTAL
Intervention: 5* GRIP-rated slip-resistant footwear
Number of subjects: 4553
Study 35414517 — intervention group
Group type: COMPARATOR
Intervention: Usual work footwear (Control)
Number of subjects: 4553
Study 35258839 — intervention group
Group type: EXPERIMENTAL
Intervention: TA-ER 32 mg
Number of subjects: 30
Study 35258839 — intervention group
Group type: COMPARATOR
Intervention: TAcs 40 mg
Number of subjects: 30
Study 34927787 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertensive disorders of pregnancy (HDP)
Number of subjects: 2718
Study 34927787 — intervention group
Group type: COMPARATOR
Intervention: Normotensive
Number of subjects: 2718
Study 34531416 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NFT) group (n=25)
Number of subjects: 48
Study 34531416 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 48
Study 34620545 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy to obtain sexual consent (females)
Number of subjects: 2291
Study 34620545 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication about condom use (females)
Number of subjects: 2291
Study 34620545 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication about HIV prevention (females)
Number of subjects: 2291
Study 34620545 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/sexually transmitted infection prevention communication (Black and other race students)
Number of subjects: 2291
Study 34620545 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent condom use (students with high self-efficacy and communication)
Number of subjects: 2291
Study 32056985 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity negative ion patch treatment
Number of subjects: 0
Study 32056985 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32483770 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (0.3 μg/kg)
Number of subjects: 31
Study 32483770 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (2 ng/kg)
Number of subjects: 31
Study 32483770 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 31
Study 32746071 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive training using the proposed curriculum
Number of subjects: 24